Bistability in the Isocitrate Dehydrogenase Reaction: An Experimentally Based Theoretical Study

Abstract

The enzyme isocitrate dehydrogenase (IDH, EC 1.1.1.42) can exhibit activation by one of its products, NADPH. This activation is competitively inhibited by the substrate NADP+, whereas NADPH competes with NADP+ for the catalytic site. Experimental observations briefly presented here have shown that if IDH is coupled to another enzyme, diaphorase (EC 1.8.1.4), which transforms NADPH into NADP+, the system can attain either one of two stable states, corresponding to a low and a high NADPH concentration. The evolution toward either one of these stable states depends on the time of addition of diaphorase to the medium containing IDH and its substrate NADP+. We present a theoretical and numerical analysis of a model for the IDH-diaphorase bienzymatic system, based on the regulatory properties of IDH. The results confirm the occurrence of bistability for parameter values derived from the experiments. Depending on the total concentration of NADP+ plus NADPH and the concentration of IDH, the system can either admit a single steady state or display bistability. We obtain an expression for the critical time t*, before which diaphorase addition leads to the lower steady state and after which addition of the enzyme leads to the upper steady state of NADPH. The analysis is extended to the case where the second substrate of IDH, isocitrate, is consumed in the course of the reaction without being regenerated. Bistability occurs only as a transient phenomenon in these conditions.

Endocytosis as a stabilizing mechanism for tissue homeostasis

“…The system also has another fixed point: Below a certain initial concentration of T cells the population decays to zero cells, converging to a stable OFF state ( 14 , 18 ). A stable OFF state in addition to a stable ON state is a form of bistability ( 24 – 28 ). The OFF state may help to avoid unwanted fluctuations in which a small group of cells expands to give rise to a new tissue.…”

The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS

“…Instead, the trap hypothesis identifies substrate inhibition, an inherent and well-studied feature of some enzymes that can, in response to pathogenic triggers, unmask metabolic bistability. Bistability is a phenomenon unique to nonlinear dynamics that has been studied for decades [23,24,58,59]. The essential fact of bistability is that it is possible for a bistable system to be driven into an alternative (e.g., pathological) steady-state and be maintained in that chronic disease state long after the trigger is removed and without requiring a chronic infection or chronic exposure to a toxin .…”

Sharp developmental thresholds defined through bistability by antagonistic gradients of retinoic acid and FGF signaling

“…Bistability is a widespread phenomenon in biological systems (Thomas and d'Ari, 1990;Ferrell, 2002) in which it can readily arise as a result of positive feedback (Lisman, 1985;Guidi et al, 1998;Bhalla et al, 2002;Xiong and Ferrell, 2003;Ozbudak et al, 2004). It can also originate from mutual inhibition of two regulatory factors (Monod and Jacob, 1961), as shown by mathematical models (Meinhardt, 1982;Keller, 1995;Cherry and Adler, 2000) and demonstrated experimentally in a synthetic genetic system (Gardner et al, 2000).…”